Holen Sie sich die Stockscreener-App
28.62
4.02%
-1.20
Handel nachbörslich:
29.06
0.44
+1.54%
Finanzdaten der Newamsterdam Pharma Company Nv-Aktie (NAMS)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
90.80%
0.032
|
0.348 | 19.14 | 2.978 | 12.77 |
Operating Expenses
|
18.96%
66.01
|
55.49 | 54.78 | 71.90 | 56.00 |
| Benefits Costs and Expenses |
3.60%
74.95
|
72.35 | 36.51 | 42.51 | 104.95 |
| Costs And Expenses |
3.60%
74.95
|
72.35 | 36.51 | 42.51 | 104.95 |
| Depreciation and Amortization |
6.40%
0.133
|
0.125 | 0.107 | 0.113 | - |
| Operating Income/Loss |
19.65%
-65.98
|
-55.14 | -35.63 | -68.92 | -43.23 |
| Income/Loss From Continuing Operations Before Tax |
4.05%
-74.92
|
-72.00 | -17.36 | -39.53 | -92.18 |
| Income/Loss From Continuing Operations After Tax |
4.05%
-74.92
|
-72.00 | -17.36 | -39.53 | -92.18 |
|
Net Income/Loss
|
4.05%
-74.92
|
-72.00 | -17.36 | -39.53 | -92.18 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
99.56%
0.5198
|
119.00 | 118.56 | 116.12 | 1.6912 |
| Diluted Average Shares |
99.56%
0.5198
|
119.00 | 118.56 | 116.12 | 1.6912 |
| Basic Earnings Per Share |
3.28%
-0.63
|
-0.61 | -0.15 | -0.34 | -0.95 |
| Diluted Earnings Per Share |
3.28%
-0.63
|
-0.61 | -0.15 | -0.34 | -0.95 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.48%
1.21%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):